androstane-3,17-diol has been researched along with Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graf, MR; Jia, W; Loria, RM | 1 |
1 other study(ies) available for androstane-3,17-diol and Lymphoma
| Article | Year |
|---|---|
The neuro-steroid, 3beta androstene 17alpha diol exhibits potent cytotoxic effects on human malignant glioma and lymphoma cells through different programmed cell death pathways.
Topics: Androstane-3,17-diol; Apoptosis; Blotting, Western; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Flow Cytometry; Glioma; Humans; In Situ Nick-End Labeling; Lymphoma; Molecular Structure; Phagosomes; Poly(ADP-ribose) Polymerases; Signal Transduction; U937 Cells | 2007 |